
Groundwork BioAg
Groundwork BioAg produces highly-effective mycorrhizal inoculants for commercial agriculture to improve crop yields and plant health.
About
Groundwork BioAg is an agricultural biotechnology company that develops and produces highly-effective mycorrhizal inoculants for commercial farming. Their Rootella™ products contain concentrated beneficial fungi that significantly enhance soil nutrient uptake in plants, leading to increased crop yields and improved resistance to various stresses. The company aims to make mycorrhizal technology a cornerstone of sustainable and profitable agriculture.
Key facts
At-a-glance profile data
- Website
- groundworkbioag.com
- Headquarters
- Mazor, Israel
- Founded
- 2013
- Employees
- 54
- Total funding
- $29M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 18 Aug 2022 | Series B | $18M | Climate Innovation Capital |
| 12 May 2021 | Funding Round | $11M | - |
Tech stack
Detected on groundworkbioag.com, last scanned 18 Sept 2026. Run your own scan
- Frontend
- jQuery
- Backend
- PHP
- Analytics
- Google Tag Manager
- SEO
- Yoast SEO
- Hosting
- Hetzner
- Email provider
- Google Workspace
Frequently asked
How much funding has Groundwork BioAg raised?
Groundwork BioAg has raised a total of $29M in funding. The most recent round on record is Series B.
How many employees does Groundwork BioAg have?
Groundwork BioAg has approximately 54 people on record.